Clinical Trial Update: A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) [Phase 2]

View source ↗

Summary

Phase 2 GATHER trial evaluating obinutuzumab in combination with CHOP for previously untreated advanced diffuse large B-cell lymphoma; the study is completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Obinutuzumab (obinutuzumab)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Genentech, Inc. | Conditions: Lymphoma, B-Cell | Phase 2 | Status: COMPLETED | Results posted: 2015-03-19